PURA Announces CBD Confections Acquisition Fairness Opinion
February 19 2020 - 9:26AM
InvestorsHub NewsWire
PURA Announces CBD Confections
Acquisition Fairness Opinion
Dallas, TX -- February 19, 2020 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced the recent offer PURA made to acquire a
CBD Confections Operation has been accepted by the seller. In
conjunction with the terms of the acquisition agreement, an
independent third party has been engaged to evaluate the CBD
Confections Operation and render a fairness opinion. The fairness
opinion is expected within the next two
weeks.
PURA recently launched a campaign to
acquire CBD infused beverage, edible and topical operations and
also announced closing on a $5 million investment to fund the
acquisition campaign. The $5 million investment is structured as a
debt facility whereby funds can be drawn as needed to fund
acquisitions. The drawn funds would be secured by the
acquired asset and the debt can be repaid in stock at $0.10 per
share.
In addition to PURA’s offer to acquire a
CBD Confections Operation, PURA has separately made an offer to
acquire a CBD Pet Products operation. PURA plans to also
engage an independent evaluation of the CBD Pet Products operation
if the offer is accepted.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024